Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001195775 | SCV001366195 | uncertain significance | Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity | 2020-01-30 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: No criteria apply. |
Labcorp Genetics |
RCV001452879 | SCV001656556 | likely benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001452879 | SCV002563767 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | PTPN23: BS2 |
Regeneron Genetics Center, |
RCV000853203 | SCV000927110 | likely pathogenic | Global developmental delay; Brain atrophy | 2019-02-15 | no assertion criteria provided | research | Identified in cohort of patients with neurodevelopmental disorder accompanied by structural brain abnormalities |